Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 40.235K |
Day Range | - - - |
52 Wk Range | 1.010 - 7.120 |
Market Cap | $34.589M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 72 |
Short Interest | 0.8% |
Days to Cover | 1.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aileron Therapeutics (NASDAQ: ALRN) through any online brokerage.
Other companies in Aileron Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Sensei Biotherapeutics (NASDAQ:SNSE) and Viracta Therapeutics (NASDAQ:VIRX).
The latest price target for Aileron Therapeutics (NASDAQ: ALRN) was reported by Ladenburg Thalmann on Friday, December 1, 2023. The analyst firm set a price target for 9.00 expecting ALRN to rise to within 12 months (a possible 27.12% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $7.08 last updated March 27, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Aileron Therapeutics.
Aileron Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Aileron Therapeutics.
Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.